Murata K, Kusachi S, Murakami T, Nogami K, Murakami M, Hirohata S, Tominaga Y, Komatsubara I, Tsuji T
First Department of Internal Medicine, Okayama University Medical School, Japan.
Clin Cardiol. 1997 Jan;20(1):61-6. doi: 10.1002/clc.4960200113.
Iodine-123 metaiodobenzylguanidine (123I-MIBG) concentrates in adrenergic neurons and has been developed for evaluation of the sympathetic nervous system. Recent studies have demonstrated that the normal heart is clearly visualized by 123I-MIBG cardiac scintigraphy, whereas abnormal 123I-MIBG myocardial uptake and washout have been demonstrated in patients after myocardial infarction and in patients with congestive cardiomyopathy, long QT syndrome, and ventricular tachycardia.
Based on evidence from recent studies, it can be hypothesized that 123I-MIBG uptake is related to histopathologic changes in the myocardium.
The relation of 123I-MIBG uptake to the histologic findings for the heart was studied in 24 patients with dilated cardiomyopathy (DCM). The study group did not include patients with complicating disorders that primarily affect the adrenergic nervous system. The 123I-MIBG uptake was visually assigned one of four grades using the two criteria of the mean score for six regional uptake grades (mean score) and the global score obtained by visual evaluation of the entire image (global score). The 123I-MIBG uptake score was also determined for the region at which the biopsy specimen was obtained (biopsy region score). The histologic findings were evaluated by assigning one of four grades for each of the following five factors: myocyte hypertrophy, myocardial fibrotic change, myocyte degeneration and necrosis, mononuclear cell infiltration, and myocyte disarray. The sum for all grades was defined as the total score, and the global score was also assigned to the overall histologic findings.
All of the global, mean, and biopsy region scores for 123I-MIBG uptake correlated significantly with the global and total scores for the histologic findings. Among the histologic factors, myocyte degeneration showed score correlated with all global, mean, and biopsy region scores for the uptake. Myocyte hypertrophy was associated weakly with the 123I-MIBG uptake scores.
These results indicate that 123I-MIBG uptake imaging is associated with histopathologic abnormalities in patients with DCM.
碘-123间碘苄胍(123I-MIBG)可在肾上腺素能神经元中聚集,已被用于评估交感神经系统。最近的研究表明,123I-MIBG心肌闪烁显像能清晰显示正常心脏,而心肌梗死患者、充血性心肌病患者、长QT综合征患者和室性心动过速患者的123I-MIBG心肌摄取及洗脱异常。
基于近期研究证据,可推测123I-MIBG摄取与心肌组织病理学改变有关。
对24例扩张型心肌病(DCM)患者研究了123I-MIBG摄取与心脏组织学检查结果的关系。研究组不包括主要影响肾上腺素能神经系统的并发疾病患者。根据六个区域摄取等级的平均评分(平均分)和通过对整个图像进行视觉评估获得的整体评分这两个标准,将123I-MIBG摄取视觉上分为四个等级之一。还确定了获取活检标本区域的123I-MIBG摄取评分(活检区域评分)。通过对以下五个因素分别评定四个等级之一来评估组织学检查结果:心肌细胞肥大、心肌纤维化改变、心肌细胞变性和坏死、单核细胞浸润以及心肌细胞排列紊乱。所有等级的总和定义为总分,整体组织学检查结果也给予整体评分。
123I-MIBG摄取的所有整体、平均和活检区域评分与组织学检查结果的整体和总分均显著相关。在组织学因素中,心肌细胞变性的评分与摄取的所有整体、平均和活检区域评分相关。心肌细胞肥大与123I-MIBG摄取评分的相关性较弱。
这些结果表明,123I-MIBG摄取显像与DCM患者的组织病理学异常有关。